Relmada Therapeutics, Inc. RLMD Deferred Tax Assets Capitalized Ramp D
Deferred Tax Assets Capitalized Ramp D at other companies
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept rlmd:DeferredTaxAssetsCapitalizedRampD.
The official record: Relmada Therapeutics, Inc.’s 10-K, filed March 19, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s deferred tax assets capitalized ramp d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s deferred tax assets capitalized ramp d?
- Relmada Therapeutics, Inc. (RLMD) reported deferred tax assets capitalized ramp d of $35.9M in Q4 2025.
- What does deferred tax assets capitalized ramp d mean?
- This metric represents the value of deferred tax assets arising from the capitalization of research and development expenditures for tax reporting purposes. It reflects the future tax benefits expected to be realized as these capitalized costs are amortized or deducted over time. Monitoring this balance provides insight into the company's tax planning strategy regarding long-term investment in clinical-stage drug development.